All In MedTech

FDA Clearance Tracker · P170003-S007

LUTONIX® 035 Drug Coated Balloon PTA Catheter

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 4, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 4, 2019

Approved

Time to decision

177 days

Received Apr 10, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P170003-S007
Device name
LUTONIX® 035 Drug Coated Balloon PTA Catheter
Applicant
Lutonix
Applicant location
New Hope, MN
Received
Apr 10, 2019
Decided
Oct 4, 2019
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P170003

Device type

Device class
Class III

Every decision under product code PRC

FDA's approval statement

As written in FDA's record.

Approval for updates to the Instructions for Use for the Lutonix 035 Model 9010 to reflect the 24-month data from the AV IDE Cohort Post-Approval Study.

Source documents

Other decisions for Lutonix

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.